HMOX1 and infarction: The beneficial effect of such treatment on infarct size, cardiac function and ventricular remodeling implies the ‘late’ occurrence of non-obvious cellular phenomena that can be addressed by pharmacological intervention in HO-1 up-regulation and positively modify final outcome.